CELC
Celcuity Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -12.5% ·
share flow -2.7% ·
net new positions -14.3%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +6 | 24.27M | $2.54B | +12 | −6 |
| Q1 2026 | 96 | +13 | 18.05M | $2.05B | +17 | −5 |
| Q4 2025 | 83 | -2 | 17.89M | $1.79B | +1 | −2 |
| Q3 2025 | 16 | +3 | 9.73M | $480.43M | +3 | — |
| Q2 2025 | 10 | 0 | 5.98M | $79.79M | +1 | −1 |
| Q1 2025 | 7 | 0 | 2.39M | $24.13M | — | — |
| Q4 2024 | 7 | -1 | 2.58M | $33.71M | +1 | −2 |
| Q3 2024 | 7 | -1 | 1.77M | $26.33M | +1 | −2 |
| Q2 2024 | 8 | — | 1.21M | $19.80M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 879.79K | — | $11.52M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 836.02K | +7.9% | $10.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 836.02K | +7.9% | $10.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 692.37K | +9.8% | $9.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 692.37K | +9.8% | $9.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 62.78K | +21.6% | $821,738 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 62.78K | +21.6% | $821,738 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 51.84K | -61.0% | $678,559 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Millennium Management ✦ | 39.66K | -74.1% | $519,149 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 12.72K | New | $167,000 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| T. Rowe Price | $167,000 | 0.0% |
Exited
| Marshall Wace | $177,086 | was 0.0% |
| Renaissance Technologies | $164,681 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 275 holders, 48.99M shares, $5.37B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
10.0% of class · View original SEC filing ↗